9.305  0.005 (0.05%)		04-30 10:44
Open: 9.32 High: 9.37 Volume: 2,264,942		Pre. Close: 9.3 Low: 9.295 Market Cap: 41,395(M)

Short term
Mid term
Targets	6-month :	11.25	1-year :	11.67
Resists	First :	9.63	Second :	9.99
Pivot price	9.57
Supports	First :	9.06	Second :	7.54
MAs	MA(5) :	9.43	MA(20) :	9.63
	MA(100) :	10.03	MA(250) :	9.83
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	25.1	D(3) :	25.1
RSI	RSI(14): 35.5
52-week	High :	11.2	Low :	8.59

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ HLN ] has closed above bottom band by 11.9%. Bollinger Bands are 22% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	9.35 - 9.41	9.41 - 9.45
Low:	8.93 - 9.01	9.01 - 9.06
Close:	9.2 - 9.31	9.31 - 9.39

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Wed, 29 Apr 2026
MSN Money - MSN

Wed, 29 Apr 2026
Haleon Q1 2026 TU Earnings Call Transcript - MarketBeat

Wed, 29 Apr 2026
Strong support for Haleon (NYSE: HLN) board, pay and buyback powers - Stock Titan

Wed, 29 Apr 2026
Haleon slides Wednesday, underperforms market - MarketWatch

Wed, 29 Apr 2026
Haleon Shareholders Back All Resolutions at 2026 AGM, Endorsing Board and Capital Flexibility - TipRanks

Wed, 29 Apr 2026
Haleon plc (HLN) Q1 2026 Sales/ Trading Statement Call - Slideshow (NYSE:HLN) 2026-04-29 - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	4,450 (M)
Shares Float	8,860 (M)
Held by Insiders	0 (%)
Held by Institutions	12.7 (%)
Shares Short	19,280 (K)
Shares Short P.Month	17,020 (K)

EPS	0.5
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	4.98
Profit Margin	15.1 %
Operating Margin	23.1 %
Return on Assets (ttm)	4.6 %
Return on Equity (ttm)	10.2 %
Qtrly Rev. Growth	0.6 %
Gross Profit (p.s.)	1.6
Sales Per Share	2.47
EBITDA (p.s.)	0.61
Qtrly Earnings Growth	92 %
Operating Cash Flow	2,630 (M)
Levered Free Cash Flow	1,400 (M)

PE Ratio	18.64
PEG Ratio	2.5
Price to Book value	1.86
Price to Sales	3.76
Price to Cash Flow	15.77

Dividend	0.12
Forward Dividend	0
Dividend Yield	1.3%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.